Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells
Vanadium compounds were studied in recent years by considering them as a representative of a new class of non-platinum metal anticancer drugs. However, a few challenges still remain in the discovery of new molecular targets of these new metallodrugs. Studies on cell signaling pathways related to van...
Guardado en:
| Autores principales: | León, Ignacio Esteban, Díez, Paula, Baran, Enrique José, Etcheverry, Susana Beatriz, Fuentes, Manuel |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/108044 https://pubs.rsc.org/en/content/articlelanding/2017/MT/C7MT00068E |
| Aporte de: |
Ejemplares similares
-
Data from: Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells
por: León, Ignacio Esteban, et al.
Publicado: (2020) -
In silico and in vitro analysis of FAK/MMP signaling axis inhibition by VO-clioquinol in 2D and 3D human osteosarcoma cancer cells
por: Balsa, Lucía Mariana, et al.
Publicado: (2020) -
Vanadium(IV) complexes inhibit adhesion, migration and colony formation of UMR106 osteosarcoma cells
por: Molinuevo, María Silvina, et al.
Publicado: (2008) -
In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice
por: León, Ignacio Esteban, et al.
Publicado: (2016) -
Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells
por: León, Ignacio Esteban, et al.
Publicado: (2014)